Pharmacovigilance Market Size Set to Increase
The global pharmacovigilance market continues to expand with some estimates forecasting an increase to $12.98 billion by 2027. The need to monitor adverse drug reactions and drug toxicity has been recognized as vital by the World Health Organization, which estimates that around 5% of hospitalized patients are already admitted with an adverse drug reaction. The same source indicates that up to 10% of patients are likely to experience an adverse drug reaction during hospitalization, placing additional emphasis on the need...
View full press release